BRIEF published on 03/24/2026 at 16:06, 23 days 12 hours ago Northwest Biotherapeutics Gains Positive Outlook with Innovative Therapy Regulatory Approval Glioblastoma Treatment Northwest Biotherapeutics DCVax-L Therapy Oncology Innovations
PRESS RELEASE published on 03/24/2026 at 16:01, 23 days 12 hours ago Original-Research: Northwest Biotherapeutics Inc. (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research initiates coverage on Northwest Biotherapeutics Inc., with a Buy rating and USD 1.00 price target. Company is developing DCVax-L for glioblastoma First Berlin Equity Research BUY Rating Coverage Northwest Biotherapeutics Inc. DCVax-L
Published on 04/17/2026 at 02:13, 2 hours 23 minutes ago CHAR Tech annonce l’acquisition projetée d’actifs de biocarbone au Québec, incluant un accord d’achat de 62 500 tonnes, une installation et de la propriété intellectuelle
Published on 04/17/2026 at 02:00, 2 hours 36 minutes ago UraniumX Announces Closing Of Final Tranche Of Non-Brokered Private Placement
Published on 04/16/2026 at 23:32, 5 hours 4 minutes ago Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale
Published on 04/16/2026 at 21:30, 7 hours 6 minutes ago Organto Foods Expands Financing Facilities with Rabobank
Published on 04/16/2026 at 23:40, 4 hours 56 minutes ago Coventry Ranks #1 in 2025 Life Settlement League Table Report
Published on 04/16/2026 at 21:37, 6 hours 59 minutes ago Approval of the Offer Document concerning the voluntary tender offer for shares of NEXT RE SIIQ S.p.A.
Published on 04/16/2026 at 21:00, 7 hours 36 minutes ago Vizrt AI Keyer kills the green screen and creates virtual scenes in any environment
Published on 04/16/2026 at 20:35, 8 hours 1 minute ago EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 19:17, 9 hours 19 minutes ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 18:02, 10 hours 34 minutes ago Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
Published on 04/16/2026 at 17:54, 10 hours 42 minutes ago Aéroports de Paris S.A - March 2026 traffic figures
